These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. Sastry BK; Narasimhan C; Reddy NK; Raju BS J Am Coll Cardiol; 2004 Apr; 43(7):1149-53. PubMed ID: 15063421 [TBL] [Abstract][Full Text] [Related]
25. Sildenafil citrate in the treatment of pain in primary dysmenorrhea: a randomized controlled trial. Dmitrovic R; Kunselman AR; Legro RS Hum Reprod; 2013 Nov; 28(11):2958-65. PubMed ID: 23925396 [TBL] [Abstract][Full Text] [Related]
26. Sildenafil improves walk distance in idiopathic pulmonary fibrosis. Collard HR; Anstrom KJ; Schwarz MI; Zisman DA Chest; 2007 Mar; 131(3):897-899. PubMed ID: 17356110 [TBL] [Abstract][Full Text] [Related]
27. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease. Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015 [TBL] [Abstract][Full Text] [Related]
28. Sildenafil for pulmonary hypertension: need for evidence generation. Shafiq N; Reddy S; Pandhi P; Manoj R; Talwar KK; Malhotra S Int J Clin Pharmacol Ther; 2008 Dec; 46(12):644-51. PubMed ID: 19049698 [TBL] [Abstract][Full Text] [Related]
29. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546 [TBL] [Abstract][Full Text] [Related]
30. Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Goldberg DJ; French B; McBride MG; Marino BS; Mirarchi N; Hanna BD; Wernovsky G; Paridon SM; Rychik J Circulation; 2011 Mar; 123(11):1185-93. PubMed ID: 21382896 [TBL] [Abstract][Full Text] [Related]
31. Ventilatory efficiency and dyspnea on exertion improvements are related to reduced pulmonary pressure in heart failure patients receiving Sildenafil. Guazzi M; Myers J; Peberdy MA; Bensimhon D; Chase P; Arena R Int J Cardiol; 2010 Oct; 144(3):410-2. PubMed ID: 19329196 [TBL] [Abstract][Full Text] [Related]
32. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ghofrani HA; Reichenberger F; Kohstall MG; Mrosek EH; Seeger T; Olschewski H; Seeger W; Grimminger F Ann Intern Med; 2004 Aug; 141(3):169-77. PubMed ID: 15289213 [TBL] [Abstract][Full Text] [Related]
33. Sildenafil improves skeletal muscle oxygenation during exercise in men with intermittent claudication. Roseguini BT; Hirai DM; Alencar MC; Ramos RP; Silva BM; Wolosker N; Neder JA; Nery LE Am J Physiol Regul Integr Comp Physiol; 2014 Aug; 307(4):R396-404. PubMed ID: 24944249 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review. Wang RC; Jiang FM; Zheng QL; Li CT; Peng XY; He CY; Luo J; Liang ZA Respir Med; 2014 Mar; 108(3):531-7. PubMed ID: 24462476 [TBL] [Abstract][Full Text] [Related]
35. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial. Tapson VF; Torres F; Kermeen F; Keogh AM; Allen RP; Frantz RP; Badesch DB; Frost AE; Shapiro SM; Laliberte K; Sigman J; Arneson C; Galiè N Chest; 2012 Dec; 142(6):1383-1390. PubMed ID: 22628490 [TBL] [Abstract][Full Text] [Related]
37. Oral sildenafil therapy for Chinese patients with pulmonary arterial hypertension: a multicenter study. Xiong CM; Lu XL; Shan GL; Wu BX; Zhu XY; Wu GH; Zeng XF; Guo T; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Tian HY; Li WM; Zhang DZ; Zhang C; Li MT; Liu HM; Guo YJ; Shen JY; Zhang WJ; Liu S; Zhou DX; Bao CD; Huang SA; Chen JY; Wu WF; Huang K; Li CL; Wang LH; He B; He JG; Li JJ J Clin Pharmacol; 2012 Mar; 52(3):425-31. PubMed ID: 21415281 [TBL] [Abstract][Full Text] [Related]
38. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis]. Kuang TG; Wang J; Zhai ZG; Guo XH; Wang C Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1021-4. PubMed ID: 17672963 [TBL] [Abstract][Full Text] [Related]
39. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease? Madden BP; Sheth A; Wilde M; Ong YE Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899 [TBL] [Abstract][Full Text] [Related]